Good MF - Search Results

1

Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.

Moyle PM, Olive C, Ho MF, Good MF, Toth I. Moyle PM, et al. Among authors: good mf. J Med Chem. 2006 Oct 19;49(21):6364-70. doi: 10.1021/jm060475m. J Med Chem. 2006. PMID: 17034142

2

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.

Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, Hunsakunachai S, Manmontri A, Good MF. Pruksakorn S, et al. Among authors: good mf. Lancet. 1994 Sep 3;344(8923):639-42. doi: 10.1016/s0140-6736(94)92083-4. Lancet. 1994. PMID: 7520963

3

Intranasal immunisation of mice with a streptococcal peptide-based vaccine.

Relf W, Hayman W, Russell-Jones G, Good M. Relf W, et al. Adv Exp Med Biol. 1997;418:859-61. doi: 10.1007/978-1-4899-1825-3_204. Adv Exp Med Biol. 1997. PMID: 9331788 No abstract available.

4

Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.

Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Hayman WA, et al. Among authors: good mf. Int Immunol. 1997 Nov;9(11):1723-33. doi: 10.1093/intimm/9.11.1723. Int Immunol. 1997. PMID: 9418133

5

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF. Brandt ER, et al. Among authors: good mf. Nat Med. 2000 Apr;6(4):455-9. doi: 10.1038/74719. Nat Med. 2000. PMID: 10742155

6

Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Brandt ER, Teh T, Relf WA, Hobb RI, Good MF. Brandt ER, et al. Among authors: good mf. Infect Immun. 2000 Dec;68(12):6587-94. doi: 10.1128/IAI.68.12.6587-6594.2000. Infect Immun. 2000. PMID: 11083769 Free PMC article.

7

Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations.

Brandt ER, Yarwood PJ, McMillan DJ, Vohra H, Currie B, Mammo L, Pruksakorn S, Saour J, Good MF. Brandt ER, et al. Among authors: good mf. Int Immunol. 2001 Oct;13(10):1335-43. doi: 10.1093/intimm/13.10.1335. Int Immunol. 2001. PMID: 11581178

8

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Horvath A, et al. J Med Chem. 2002 Mar 14;45(6):1387-90. doi: 10.1021/jm0110441. J Med Chem. 2002. PMID: 11882009

9

Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.

Hayman WA, Toth I, Flinn N, Scanlon M, Good MF. Hayman WA, et al. Among authors: good mf. Immunol Cell Biol. 2002 Apr;80(2):178-87. doi: 10.1046/j.1440-1711.2002.01067.x. Immunol Cell Biol. 2002. PMID: 11940119

10

Progress towards developing a vaccine for group A streptococcus based on the M protein.

Good MF. Good MF. Intern Med J. 2002 Apr;32(4):132-3. doi: 10.1046/j.1444-0903.2001.00203.x. Intern Med J. 2002. PMID: 11951921 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters